Associated Papers
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ.
Luo H et al.
Cell Death and Differentiation, 2025
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.
Wang Y et al.
Acta Pharmaceutica Sinica. B, 2024
Select a paper to view details